CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter's five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Rise in incidence of hospital-acquired infections (HAIs)
3.5.1.2.Upsurge in likelihood of epidemic or pandemic outbreaks
3.5.1.3.Increase in geriatric population and rise in incidence of chronic diseases
3.5.1.4.Rise in use of E-beam sterilization

3.5.2.Restraint

3.5.2.1.Adverse effects of chemical disinfectants

3.5.3.Opportunities

3.5.3.1.Growth opportunities in emerging markets

3.5.4.Impact analysis

3.6.Covid-19 Impact analysis on infection control market

CHAPTER 4:INFECTION CONTROL MARKET, BY PRODUCT & SERVICE

4.1.Overview

4.1.1.Market size and forecast

4.2.Sterilization

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Market size and forecast, by type

4.2.4.1.Sterilization product

4.2.4.1.1.Market size and forecast
4.2.4.1.2.Market size and forecast, by type

4.2.4.1.2.1.Heat sterilization equipment

4.2.4.1.2.1.1.Market size and forecast

4.2.4.1.2.2.Low temperature sterilization equipment

4.2.4.1.2.2.1.Market size and forecast

4.2.4.1.2.3.Radiation sterilization equipment

4.2.4.1.2.3.1.Market size and forecast

4.2.4.1.2.4.Other sterilization equipment

4.2.4.1.2.4.1.Market size and forecast

4.2.4.2.Contract sterilization services

4.2.4.2.1.Market size and forecast
4.2.4.2.2.Market size and forecast, by type

4.2.4.2.2.1.Ethylene oxide sterilization

4.2.4.2.2.1.1.Market size and forecast

4.2.4.2.2.2.E-beam sterilization

4.2.4.2.2.2.1.Market size and forecast

4.2.4.2.2.3.Gamma sterilization

4.2.4.2.2.3.1.Market size and forecast

4.2.4.2.2.4.Others

4.2.4.2.2.4.1.Market size and forecast

4.2.4.3.Sterilization consumables and accessories

4.2.4.3.1.Market size and forecast
4.2.4.3.2.Market size and forecast, by type

4.2.4.3.2.1.Sterilization indicators

4.2.4.3.2.1.1.Market size and forecast

4.2.4.3.2.2.Packaging accessories

4.2.4.3.2.2.1.Market size and forecast

4.3.Cleaning & Disinfection Products

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.3.4.Market size and forecast, by type

4.3.4.1.Disinfectants

4.3.4.1.1.Market size and forecast
4.3.4.1.2.Market size and forecast, by type

4.3.4.1.2.1.Wipes

4.3.4.1.2.1.1.Market size and forecast

4.3.4.1.2.2.Liquids

4.3.4.1.2.2.1.Market size and forecast

4.3.4.1.2.3.Sprays

4.3.4.1.2.3.1.Market size and forecast

4.3.4.2.Disinfectors equipment

4.3.4.2.1.Market size and forecast

4.3.4.3.Others

4.3.4.3.1.Market size and forecast

4.4.Protective Barriers

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.4.4.Market size and forecast, by type

4.4.4.1.Medical Nonwoven

4.4.4.1.1.Market size and forecast
4.4.4.1.2.Market size and forecast, by type

4.4.4.1.2.1.Surgical gowns

4.4.4.1.2.1.1.Market size and forecast

4.4.4.1.2.2.Face masks

4.4.4.1.2.2.1.Market size and forecast

4.4.4.1.2.3.Coveralls

4.4.4.1.2.3.1.Market size and forecast

4.4.4.1.2.4.Others

4.4.4.1.2.4.1.Market size and forecast

4.4.4.2.Gloves

4.4.4.2.1.Market size and forecast

4.5.Endoscope reprocessing products

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country

CHAPTER 5:INFECTION CONTROL MARKET, BY END USER

5.1.Overview

5.1.1.Market size and forecast

5.2.Hospitals & clinics

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Pharmaceutical & medical device companies

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.Others

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

CHAPTER 6:INFECTION CONTROL MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast

6.2.North America

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by country

6.2.2.1.U.S.

6.2.2.1.1.U.S. infection control market, by product & service
6.2.2.1.2.U.S. infection control market, by end user

6.2.2.2.Canada

6.2.2.2.1.Canada infection control market, by product & service
6.2.2.2.2.Canada infection control market, by end user

6.2.2.3.Mexico

6.2.2.3.1.Mexico infection control market, by product & service
6.2.2.3.2.Mexico infection control market, by end user
6.2.3.North America market size and forecast, by product & service
6.2.4.North America market size and forecast, by end user

6.3.Europe

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by country

6.3.2.1.Germany

6.3.2.1.1.Germany infection control market, by product & service
6.3.2.1.2.Germany infection control market, by end user

6.3.2.2.France

6.3.2.2.1.France infection control market, by product & service
6.3.2.2.2.France infection control market, by end user

6.3.2.3.UK

6.3.2.3.1.UK infection control market, by product & service
6.3.2.3.2.UK infection control market, by end user

6.3.2.4.Italy

6.3.2.4.1.Italy infection control market, by product & service
6.3.2.4.2.Italy infection control market, by end user

6.3.2.5.Spain

6.3.2.5.1.Spain infection control market, by product & service
6.3.2.5.2.Spain infection control market, by end user

6.3.2.6.Rest of Europe

6.3.2.6.1.Rest of Europe infection control market, by product & service
6.3.2.6.2.Rest of Europe infection control market, by end user
6.3.3.Europe market size and forecast, by product & service
6.3.4.Europe market size and forecast, by end user

6.4.Asia-Pacific

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by country

6.4.2.1.Japan

6.4.2.1.1.Japan infection control market, by product & service
6.4.2.1.2.Japan infection control market, by end user

6.4.2.2.China

6.4.2.2.1.China infection control market, by product & service
6.4.2.2.2.China infection control market, by end user

6.4.2.3.Australia

6.4.2.3.1.Australia infection control market, by product & service
6.4.2.3.2.Australia infection control market, by end user

6.4.2.4.India

6.4.2.4.1.India infection control market, by product & service
6.4.2.4.2.India infection control market, by end user

6.4.2.5.South Korea

6.4.2.5.1.South Korea infection control market, by product & service
6.4.2.5.2.South Korea infection control market, by end user

6.4.2.6.Rest of Asia-Pacific

6.4.2.6.1.Rest of Asia-Pacific infection control market, by product & service
6.4.2.6.2.Rest of Asia-Pacific infection control market, by end user

6.4.3.Asia-Pacific market size and forecast, by product & service
6.4.4.Asia-Pacific market size and forecast, by end user

6.5.LAMEA

6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by country

6.5.2.1.Brazil

6.5.2.1.1.Brazil infection control market, by product & service
6.5.2.1.2.Brazil infection control market, by end user

6.5.2.2.Saudi Arabia

6.5.2.2.1.Saudi Arabia infection control market, by product & service
6.5.2.2.2.Saudi Arabia infection control market, by end user

6.5.2.3.South Africa

6.5.2.3.1.South Africa infection control market, by product & service
6.5.2.3.2.South Africa infection control market, by end user

6.5.2.4.Rest of LAMEA

6.5.2.4.1.Rest of LAMEA infection control market, by product & service
6.5.2.4.2.Rest of LAMEA infection control market, by end user
6.5.3.LAMEA market size and forecast, by product & service
6.5.4.LAMEA market size and forecast, by end user

CHAPTER 7:COMPANY PROFILES

7.1.3M COMPANY

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments

7.2.BELIMED AG.

7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance

7.3.ECOLAB INC.

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments

7.4.FORTIVE CORPORATION (ADVANCED STERILIZATION PRODUCTS).

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.4.6.Key strategic moves and developments

7.5.GENITGE AB.

7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments

7.6.MATACHANA GROUP.

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Key strategic moves and developments

7.7.MIELE GROUP. (STEELCO)

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio

7.8.MMM GROUP

7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio

7.9.SOTERA HEALTH INC.

7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.9.6.Key strategic moves and developments

7.10.STERIS PLC (CANTEL MEDICAL CORPORATION).

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
7.10.6.Key strategic moves and developments